Eric Lefebvre
Chief Tech/Sci/R&D Officer at PLIANT THERAPEUTICS, INC.
Net worth: 1 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ho Young Huh | M | 54 | 7 years | |
| Bernard Coulie | M | 58 | 8 years | |
| David Pyott | M | 70 | 3 years | |
| Smital Shah | F | 48 | 5 years | |
| Katharine Knobil | M | 60 | 2 years | |
| Christopher Keenan | M | - | 4 years | |
| Suzanne Bruhn | M | 60 | 8 years | |
| Monica Sandberg | M | - | 5 years | |
| Bill DeGrado | M | - | 9 years | |
| John Curnutte | M | 72 | 7 years | |
| Darren Cline | M | 59 | 1 years | |
| Thomas McCourt | M | 66 | 1 years | |
| Gayle Crowell | F | 73 | 4 years | |
| Mike Ouimette | M | 51 | 4 years | |
| Alexandre Curzi | M | - |
Fonds D Investissement De La Culture Et Des Communications, LP
 Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Chantal Champagne | F | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | 9 years |
| Gregory P. Cosgrove | M | - | 3 years | |
| Katerina Leftheris | F | - | - | |
| Rik Derynck | M | - | - | |
| Alex Thurman | M | 54 | 8 years | |
| Scott Peters | M | - | 3 years | |
| Marie Christine Cojocaru | F | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Mishima Gerhart | F | - | 1 years | |
| Laurent Dubois | M | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Keith Cummings | M | 47 | 6 years | |
| Louise Lantagne | F | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Sophie Prégent | F | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Sophie Labesse | F | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Hal Chapman | M | - | 9 years | |
| Dean Sheppard | M | - | 9 years | |
| Gilles Labranche | M | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Sylvie Jacques | F | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Hans Hull | M | 49 | 8 years | |
| Luc Fortin | M | - |
Fonds D Investissement De La Culture Et Des Communications, LP
Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | - |
| Lily Cheung | F | 51 | 1 years | |
| Scott Turner | M | 53 | 3 years | |
| Minnie Kuo | F | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sujal Shah | M | 50 | 12 years | |
| Ambrose Bailey | M | 60 | - | |
| Michael Metzger | M | 53 | - | |
| Laurent Fischer | M | 60 | 5 years | |
| Robert Wills | M | 70 | 9 years | |
| Paul Quinlan | M | 61 | 7 years | |
| Carol Brosgart | M | 72 | 7 years | |
| Pamela Vig | M | 53 | 1 years | |
| Pierre Legault | M | 63 | 2 years | |
| Klara Dickinson-Eason | F | 57 | 7 years | |
| David Hovland | M | - | 8 years | |
| Daphne Karydas | F | 49 | 3 years | |
| Ian Clements | M | 55 | 1 years | |
| Neil Exter | M | 65 | 7 years | |
| Roger J. Lias | M | 63 | 6 years | |
| Joseph H. Boccuzi | M | 77 | 3 years | |
| Dennis Podlesak | M | 66 | 1 years | |
| Stephen M. Kaufhold | M | - | - | |
| Patrick Heron | M | 53 | 1 years | |
| Caroline Loewy | F | 58 | 8 years | |
| Kurt von Emster | M | 56 | 15 years | |
| Thomas Wiggans | M | 72 | 3 years | |
| Tamar Howson | F | 75 | 9 years | |
| Gwen Melincoff | M | 72 | 2 years | |
| Eckard Weber | M | 73 | 1 years | |
| Charles Homcy | M | 75 | 7 years | |
| Michael R. Gallagher | M | 77 | 2 years | |
| Andrew Fromkin | M | 58 | 1 years | |
| Harish Shantharam | M | 44 | 1 years | |
| Adriane Brown | M | 65 | 3 years | |
| Jeffrey Cooper | M | 68 | 1 years | |
| Daniel Menold | M | 54 | 10 years | |
| Elizabeth Anderson | F | 66 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 11 years |
| Janet Dorling | F | 50 | 3 years | |
| Perry Karsen | M | 69 | - | |
| Herm Cukier | M | 57 | 5 years | |
| Cornelia Haag-Molkenteller | M | 66 | 11 years | |
| Patricia Rohane | M | - | 6 years | |
| Ian A. Critchley | M | - | 3 years | |
| Barbara Howes | F | 59 | 2 years | |
| Star Seyedkazemi | M | 50 | 1 years | |
| David Bharucha | M | 62 | 4 years | |
| Christi L. Shaw | F | 57 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 1 years |
| Dennis D. Kim | M | 54 | 2 years | |
| Christopher Peetz | M | 45 | 2 years | |
| Patrick J. O'Mara | M | 62 | 33 years | |
| Jim Datin | M | 61 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 2 years |
| Kenneth F. Boehm | M | - | 5 years | |
| Janet Vergis | F | 59 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 5 years |
| Seth V. Hetherington | M | 71 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 7 years |
| Helen Jenkins | F | 60 | - | |
| Anna M. Seal | F | 67 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | 11 years |
| Maria Hilado | F | 59 | 4 years | |
| Lewis J. Stuart | M | 64 | 2 years | |
| Robert Stewart | M | 56 | 9 years | |
| Craig D. Muir | M | - | - | |
| Matthew Walsh | M | 57 | 2 years | |
| Charles McWherter | M | 69 | 17 years | |
| Matthew Nguyen | M | 54 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | 1 years |
| Leonard Dove | M | 51 | 2 years | |
| Bryan E. Smith | M | 45 | 7 years | |
| Lisa M. DeFrancesco | F | 45 | - | |
| Thomas Nee | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 68 | 68.00% |
| Ireland | 21 | 21.00% |
| Canada | 13 | 13.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Lefebvre
- Personal Network
